Jacksonville, FL, United States of America

Annabelle Gallois-Bernos

This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: Johnson and Johnson Vision Care, Inc.. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Annabelle Gallois-Bernos. Retrieved from https://idiyas.com/inventor/annabelle-gallois-bernos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 85.7

 

 

Average Co-Inventor Count = 1.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Annabelle Gallois-Bernos: Innovator in Ophthalmic Compositions

Introduction

Annabelle Gallois-Bernos is a prominent inventor based in Jacksonville, FL (US). She has made significant contributions to the field of ophthalmology, particularly in the development of innovative treatments for ocular inflammatory conditions. With a total of 7 patents to her name, her work has the potential to improve the quality of life for many individuals suffering from eye-related ailments.

Latest Patents

One of her latest patents focuses on esters for the treatment of ocular inflammatory conditions. This invention relates to ophthalmic compositions and methods aimed at treating dry eye and other inflammatory ocular conditions. The composition comprises an esterified anti-inflammatory lipid mediator, which is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide. The majority of the anti-inflammatory lipid mediator is present in an ester form, ensuring that the compositions are substantially free of the acid form of these mediators. The anti-inflammatory lipid mediators can include polyunsaturated fatty acids, resolvins, protectins, lipoxins, prostaglandins, retinoic acids, endocannabinoids, and their metabolites. This innovative composition can be delivered topically to the ocular surface through various forms such as solutions, gels, ointments, strips, or contact lenses.

Career Highlights

Annabelle is currently associated with Johnson and Johnson Vision Care, Inc., where she continues to advance her research and development efforts in ophthalmic solutions. Her work is characterized by a commitment to enhancing therapeutic options for patients with ocular conditions.

Collaborations

Throughout her career, Annabelle has collaborated with notable colleagues, including Carrie L. Davis and Kathrine Osborn Lorenz. These partnerships have contributed to the success and impact of her inventions in the field.

Conclusion

Annabelle Gallois-Bernos stands out as an influential inventor in the realm of ophthalmic compositions. Her innovative approaches to treating ocular inflammatory conditions reflect her dedication to improving patient care and advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…